[1] Polyzos SA, Kountouras J, Zavos C, et al. Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol, 2012, 46: 272-284.
[2] Haas JT, Francque S, Staels B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu Rev Physiol, 2016,78:181-205.
[3] Polyzos SA, Mantzoros CS. Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism,2014,63:161-167.
[4] Agopian VG, Kaldas FM, Hong JC, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg, 2012,256: 624-633.
[5] Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res,2012,2012:145754.
[6] Hamaguchi M, Kojima T, Itoh Y, et al.The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol,2007,102: 2708-2715.
[7] Palmentieri B, de Sio I, La Mura V, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis,2006,38:485-489.
[8] Webb M, Yeshua H, Zelber-Sagi S, et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol. 2009;192:909-914.
[9] Bedossa P, Patel K.Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease. GastroenteroIogy,2016,150:1811-1822.
[10] Chen CL, Cheng YF, Yu CY, et al. Living donor liver transplantation: the Asian perspective. Transplantation,2014,97:Suppl 8:S3.
[11] Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol,2007,188:1307-1312.
[12] Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology,2006,239:105-112.
[13] Singh D, Das CJ, Baruah MP. Imaging of non alcoholic fatty liver disease: A road less travelled. Indian J Endocrinol Metab,2013,17:990- 995.
[14] Lee SS, Park SH, Kim HJ, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol,2010,52:579-585.
[15] Van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology,2010,256:159-168.
[16] Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol,2014,20:7392-7402.
[17] Hamilton G, Middleton MS, Bydder M, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging, 2009, 30:145-152.
[18] Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging,2011,34:729-749.
[19] Nobili V, Vizzutti F, Arena U, et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology,2008,48:442-448.
[20] Orlacchio A, Bolacchi F, Antonicoli M, et al. Liver elasticity in NASH patients evaluated with real-time elastography (RTE) Ultrasound Med Biol,2012,38:537-544.
[21] Palmeri ML, Wang MH, Rouze NC, et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol,2011,55:666-672.
[22] Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology,2010,51:454-462.
[23] Shi KQ, Tang JZ, Zhu XL, et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy. J Gastroenterol Hepatol, 2014,29:1149-1158.
[24] Ledinghen V, Wong GL, Vergniol J, et al. Controlled attenuation parameter for the diagnosis of steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol, 2016,31:848-855.
[25] Liu H, Fu J, Hong R, et al. Acoustic radiation force impulse elastography for the noninvasive evaluation of hepatic fibrosis in nonalcoholic fatty liver disease patients: a systematic review & Meta-analysis. PLoS One,2015,10:el27782.
[26] Singh S, Yenkatesh SK, Loomba R, et al. Magnetic resonance elastography for staging liver fibrosis in nonalcoholic fatty liver disease:a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol,2016,26:1431-1440.
[27] Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than tran sient elastography. Gastroenterology,2016,150:626-637.
[28] Cui J, Heba E, Hernandez C, et al. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study. Hepatology,2016,63:453-461. |
